Home
Digestive Health
Aor Saccharomyces Boulardii 90 Veg Capsules

Aor Saccharomyces Boulardii 90 Veg Capsules

Click to enlarge

Retail Price:

~~$43.69~~

Your Price:

$34.95 (You save $8.74)

SKU:

1156

Brand:

Aor

Description

Aor Saccharomyces Boulardii 90 Veg Capsules:

Helps with Gastrointestinal Disorders.

A non-colonizing, non-pathogenic probiotic yeast
Helps relieve diarrhea related to travel, antibiotic use and infections
Provides a clinically studied dose of 5 billion units per capsule

accharomyces boulardii is a non-pathogenic yeast that has been shown to reduce the risk of antibiotic-associated diarrhea.

Saccharomyces boulardii is a beneficial, non-pathogenic, non-colonizing species of yeast. It has been clinically recognized for its effectiveness in reducing the symptoms of antibiotic-associated diarrhea and Clostridium difficile infection, which can result from antibiotic use, hospitalization or traveling abroad. Saccharomyces boulardii significantly reduces both the risk and the duration of diarrhea. It has also been used to treat acute diarrhea and gastroenteritis in children with good results.

AOR's Saccharomyces Boulardii is an excellent companion for those traveling abroad to reduce the risk of Traveler’s diarrhea, is helpful for those experiencing antibiotic-associated diarrhea or acute diarrhea, or for anyone who has been hospitalized and treated with antibiotics. Find Aor Supplements at healthpalace.ca

Supplement Facts:

Medicinal Ingredients Per 1 Capsule:
Saccharomyces boulardii (DBVPG 6763)	250 mg/5 billion CFU*
*Colony-forming units
Non-medicinal ingredients: Capsule: hypromellose.

AOR guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, corn, nuts, peanuts, sesame seeds, sulphites, mustard, soy, dairy, eggs, fish, shellfish or any animal byproduct.

Suggested Dose:

(Adult): Take 3 capsules daily in divided doses between meals, or as directed by a qualified health care practitioner.

Cautions :

Discontinue use and consult a health care practitioner if symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days. Consult a health care practitioner if you are pregnant or breastfeeding, experiencing nausea, fever, vomiting, bloody diarrhea or severe abdominal pain. Do not use if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).

Source:

Biological fermentation

Main Applications:

Traveller's diarrhea
Antibiotic-associated diarrhea
Dysbiosis

Research:

Diarrhea

In one double-blind, placebo-controlled study of 151 patients who underwent antibiotic therapy, the rate of patients suffering from antibiotic-associated diarrhea was almost 6 ½ times higher in the placebo group than in the Saccharomyces boulardii group. Find Aor Supplements at healthpalace.ca

The largest placebo-controlled study of Saccharomyces boulardii ever conducted specifically examined its effects on TD. The double-blind study examined 3,000 Austrians who took either a placebo, 250 or 1000 mg of S. boulardii while they traveled abroad, particularly to North Africa and the near East where recorded incidents of TD were highest. The results showed that those using S. boulardii suffered ‘significantly fewer’ cases of diarrhea than those who took the placebo, and that the beneficial results were dose-dependent.

Recent studies have examined the efficacy of S. boulardii in treating acute diarrhea in children. A recent review of five clinical trials involving a total of 619 otherwise healthy infants and children with acute gastroenteritis revealed that S. boulardii ‘significantly reduced’ both the risk and the duration of diarrhea.

Potentially Helpful in Preventing IBD and UTIs

One study examined the effect of S. boulardii on the E. coli content in the colon and found a decrease in the amount of E. coli found in the stool. The authors suggested that S. boulardii could potentially be useful in preventing urinary tract infections (UTIs) since most of these originate in the colon, but more clinical trials are needed. In an animal study, S. boulardii reduced the inflammation associated with irritable bowel syndrome (IBD), which suggests that Saccharomyces could play a role in reducing the symptoms of IBD. Find Aor Supplements at healthpalace.ca

References:

Bleichner G, Blehaut H, Mentec H, Moyse D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind, placebo-controlled trial. Intensive Care Med. 1997; 23:517-523.
Can M, et al. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Med Sci Monit. 2006 Apr;12(4):PI19-22. Epub 2006 Mar 28.
Castagliuolo I, Riegler MF, Valenick L, et al. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun. 1999; 67:302-307.
Elmer GW, McFarland LV, Surawicz CM, et al. Behavior of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Aliment Pharmacol Ther. 1999; 13:1663-1668.
McFarland LV. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Med Infect Dis. 2007 Mar;5(2):97-105. Epub 2005 Dec 5.